Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion

被引:210
作者
Olszewski, MA
Noverr, MC
Chen, GH
Toews, GB
Cox, GM
Perfect, JR
Huffnagle, GB
机构
[1] Univ Michigan, Med Ctr, Div Pulm & Crit Care Med, Sch Med,Dept Internal Med, Ann Arbor, MI 48109 USA
[2] Duke Univ, Med Ctr, Dept Internal Med, Div Infect Dis, Durham, NC 27710 USA
基金
英国惠康基金;
关键词
D O I
10.1016/S0002-9440(10)63734-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Our objective was to determine the role of the cryptococcal virulence factor urease in pulmonary-to-central nervous system, dissemination, invasion, and growth. C neoformans H99, the urease knockout strain (ure1) derived from H99, and the urease restored strain ure1+URE1-1 were used for the studies. The absence of cryptococcal urease (ure1 infection) resulted in significant protection from the high mortality observed in H99-infected mice. All H99-infected mice had extremely high cryptococcal loads in their brains at the time of death, whereas only two of six animals that died of ure1 infection had detectable C neoformans in the brain. Histological analysis of the blood-to-brain invasion by C neoformans H99 demonstrated wedging of the yeasts in small capillaries, altered structure of microvessel walls, formation of mucoid cysts initiated in the proximity of damaged microcapillaries, and the absence of an inflammatory response. Direct inoculation of H99, ure1, and ure1 +URE1-1 into the brain demonstrated that urease was not required to grow in the brain. However, the dissemination patterns in the brain, spleen, and other organs after intravenous inoculation indicated that cryptococcal urease contributes to the central nervous system invasion by enhancing yeast sequestration within microcapillary beds (such as within the brain) during hematogenous spread, thereby facilitating blood-to-brain invasion by C neoformans.
引用
收藏
页码:1761 / 1771
页数:11
相关论文
共 48 条
[1]   Th1-Th2 cytokine kinetics in the bronchoalveolar lavage fluid of mice infected with Cryptococcus neoformans of different virulences [J].
Abe, K ;
Kadota, J ;
Ishimatsu, Y ;
Iwashita, T ;
Tomono, K ;
Kawakami, K ;
Kohno, S .
MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (10) :849-855
[2]   Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain [J].
Barluzzi, R ;
Brozzetti, A ;
Mariucci, G ;
Tantucci, M ;
Neglia, RG ;
Bistoni, F ;
Blasi, E .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 109 (02) :75-86
[3]  
BAVA AJ, 1993, J MED VET MYCOL, V31, P87
[4]   Cryptococcus meningoencephalitis in AIDS: parenchymal and meningeal forms [J].
Berkefeld, J ;
Enzensberger, W ;
Lanfermann, H .
NEURORADIOLOGY, 1999, 41 (02) :129-133
[5]   Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates [J].
Blackstock, R ;
Buchanan, KL ;
Adesina, AM ;
Murphy, JW .
INFECTION AND IMMUNITY, 1999, 67 (07) :3601-3609
[6]   BIOMOLECULAR EVENTS INVOLVED IN ANTICRYPTOCOCCAL RESISTANCE IN THE BRAIN [J].
BLASI, E ;
BARLUZZI, R ;
MAZZOLLA, R ;
PITZURRA, L ;
PULITI, M ;
SALEPPICO, S ;
BISTONI, F .
INFECTION AND IMMUNITY, 1995, 63 (04) :1218-1222
[7]   What makes Cryptococcus neoformans a pathogen? [J].
Buchanan, KL ;
Murphy, JW .
EMERGING INFECTIOUS DISEASES, 1998, 4 (01) :71-83
[8]  
CASADEVALL A, 1998, CRYPTOCOCCUS NEOFORM, P289
[9]   Helicobacter pylori survival in gastric mucosa by generation of a pH gradient [J].
Chen, GD ;
Fournier, RL ;
Varanasi, S ;
MahamaRelue, PA .
BIOPHYSICAL JOURNAL, 1997, 73 (02) :1081-1088
[10]   Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells [J].
Chen, SHM ;
Stins, MF ;
Huang, SH ;
Chen, YH ;
Kwon-Chung, KJ ;
Chang, Y ;
Kim, KS ;
Suzuki, K ;
Jong, AY .
JOURNAL OF MEDICAL MICROBIOLOGY, 2003, 52 (11) :961-970